104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1553 Introduced 2/4/2025, by Sen. Patrick J. Joyce SYNOPSIS AS INTRODUCED: 720 ILCS 570/208 from Ch. 56 1/2, par. 1208720 ILCS 570/309.1 new720 ILCS 570/401 from Ch. 56 1/2, par. 1401 Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards. LRB104 10684 RTM 20763 b A BILL FOR 104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1553 Introduced 2/4/2025, by Sen. Patrick J. Joyce SYNOPSIS AS INTRODUCED: 720 ILCS 570/208 from Ch. 56 1/2, par. 1208720 ILCS 570/309.1 new720 ILCS 570/401 from Ch. 56 1/2, par. 1401 720 ILCS 570/208 from Ch. 56 1/2, par. 1208 720 ILCS 570/309.1 new 720 ILCS 570/401 from Ch. 56 1/2, par. 1401 Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards. LRB104 10684 RTM 20763 b LRB104 10684 RTM 20763 b A BILL FOR
104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1553 Introduced 2/4/2025, by Sen. Patrick J. Joyce SYNOPSIS AS INTRODUCED:
720 ILCS 570/208 from Ch. 56 1/2, par. 1208720 ILCS 570/309.1 new720 ILCS 570/401 from Ch. 56 1/2, par. 1401 720 ILCS 570/208 from Ch. 56 1/2, par. 1208 720 ILCS 570/309.1 new 720 ILCS 570/401 from Ch. 56 1/2, par. 1401
720 ILCS 570/208 from Ch. 56 1/2, par. 1208
720 ILCS 570/309.1 new
720 ILCS 570/401 from Ch. 56 1/2, par. 1401
Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards.
LRB104 10684 RTM 20763 b LRB104 10684 RTM 20763 b
LRB104 10684 RTM 20763 b
A BILL FOR
SB1553LRB104 10684 RTM 20763 b SB1553 LRB104 10684 RTM 20763 b
SB1553 LRB104 10684 RTM 20763 b
1 AN ACT concerning criminal law.
2 Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
4 Section 5. The Illinois Controlled Substances Act is
5 amended by changing Sections 208 and 401 and by adding Section
6 309.1 as follows:
7 (720 ILCS 570/208) (from Ch. 56 1/2, par. 1208)
8 Sec. 208. (a) The controlled substances listed in this
9 Section are included in Schedule III.
10 (b) Unless specifically excepted or unless listed in
11 another schedule, any material, compound, mixture, or
12 preparation which contains any quantity of the following
13 substances having a stimulant effect on the central nervous
14 system, including its salts, isomers (whether optical
15 position, or geometric), and salts of such isomers whenever
16 the existence of such salts, isomers, and salts of isomers is
17 possible within the specific chemical designation;
18 (1) Those compounds, mixtures, or preparations in
19 dosage unit form containing any stimulant substances
20 listed in Schedule II which compounds, mixtures, or
21 preparations were listed on August 25, 1971, as excepted
22 compounds under Title 21, Code of Federal Regulations,
23 Section 308.32, and any other drug of the quantitative
104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026 SB1553 Introduced 2/4/2025, by Sen. Patrick J. Joyce SYNOPSIS AS INTRODUCED:
720 ILCS 570/208 from Ch. 56 1/2, par. 1208720 ILCS 570/309.1 new720 ILCS 570/401 from Ch. 56 1/2, par. 1401 720 ILCS 570/208 from Ch. 56 1/2, par. 1208 720 ILCS 570/309.1 new 720 ILCS 570/401 from Ch. 56 1/2, par. 1401
720 ILCS 570/208 from Ch. 56 1/2, par. 1208
720 ILCS 570/309.1 new
720 ILCS 570/401 from Ch. 56 1/2, par. 1401
Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards.
LRB104 10684 RTM 20763 b LRB104 10684 RTM 20763 b
LRB104 10684 RTM 20763 b
A BILL FOR
720 ILCS 570/208 from Ch. 56 1/2, par. 1208
720 ILCS 570/309.1 new
720 ILCS 570/401 from Ch. 56 1/2, par. 1401
LRB104 10684 RTM 20763 b
SB1553 LRB104 10684 RTM 20763 b
SB1553- 2 -LRB104 10684 RTM 20763 b SB1553 - 2 - LRB104 10684 RTM 20763 b
SB1553 - 2 - LRB104 10684 RTM 20763 b
1 composition shown in that list for those drugs or which is
2 the same except that it contains a lesser quantity of
3 controlled substances;
4 (2) Benzphetamine;
5 (3) Chlorphentermine;
6 (4) Clortermine;
7 (5) Phendimetrazine.
8 (c) Unless specifically excepted or unless listed in
9 another schedule, any material, compound, mixture, or
10 preparation which contains any quantity of the following
11 substances having a potential for misuse associated with a
12 depressant effect on the central nervous system:
13 (1) Any compound, mixture, or preparation containing
14 amobarbital, secobarbital, pentobarbital or any salt
15 thereof and one or more other active medicinal ingredients
16 which are not listed in any schedule;
17 (2) Any suppository dosage form containing
18 amobarbital, secobarbital, pentobarbital or any salt of
19 any of these drugs and approved by the Federal Food and
20 Drug Administration for marketing only as a suppository;
21 (3) Any substance which contains any quantity of a
22 derivative of barbituric acid, or any salt thereof:
23 (3.1) Aprobarbital;
24 (3.2) Butabarbital (secbutabarbital);
25 (3.3) Butalbital;
26 (3.4) Butobarbital (butethal);
SB1553 - 2 - LRB104 10684 RTM 20763 b
SB1553- 3 -LRB104 10684 RTM 20763 b SB1553 - 3 - LRB104 10684 RTM 20763 b
SB1553 - 3 - LRB104 10684 RTM 20763 b
1 (4) Chlorhexadol;
2 (5) Methyprylon;
3 (6) Sulfondiethylmethane;
4 (7) Sulfonethylmethane;
5 (8) Sulfonmethane;
6 (9) Lysergic acid;
7 (10) Lysergic acid amide;
8 (10.1) Tiletamine or zolazepam or both, or any salt of
9 either of them.
10 Some trade or other names for a tiletamine-zolazepam
11 combination product: Telazol.
12 Some trade or other names for Tiletamine:
13 2-(ethylamino)-2-(2-thienyl)-cyclohexanone.
14 Some trade or other names for zolazepam:
15 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-
16 [3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.
17 (11) Any material, compound, mixture or preparation
18 containing not more than 12.5 milligrams of pentazocine or
19 any of its salts, per 325 milligrams of aspirin;
20 (12) Any material, compound, mixture or preparation
21 containing not more than 12.5 milligrams of pentazocine or
22 any of its salts, per 325 milligrams of acetaminophen;
23 (13) Any material, compound, mixture or preparation
24 containing not more than 50 milligrams of pentazocine or
25 any of its salts plus naloxone HCl USP 0.5 milligrams, per
26 dosage unit;
SB1553 - 3 - LRB104 10684 RTM 20763 b
SB1553- 4 -LRB104 10684 RTM 20763 b SB1553 - 4 - LRB104 10684 RTM 20763 b
SB1553 - 4 - LRB104 10684 RTM 20763 b
1 (14) Ketamine;
2 (15) Thiopental; .
3 (16) xylazine.
4 (d) Nalorphine.
5 (d.5) Buprenorphine.
6 (e) Unless specifically excepted or unless listed in
7 another schedule, any material, compound, mixture, or
8 preparation containing limited quantities of any of the
9 following narcotic drugs, or their salts calculated as the
10 free anhydrous base or alkaloid, as set forth below:
11 (1) not more than 1.8 grams of codeine per 100
12 milliliters or not more than 90 milligrams per dosage
13 unit, with an equal or greater quantity of an isoquinoline
14 alkaloid of opium;
15 (2) not more than 1.8 grams of codeine per 100
16 milliliters or not more than 90 milligrams per dosage
17 unit, with one or more active non-narcotic ingredients in
18 recognized therapeutic amounts;
19 (3) (blank);
20 (4) (blank);
21 (5) not more than 1.8 grams of dihydrocodeine per 100
22 milliliters or not more than 90 milligrams per dosage
23 unit, with one or more active, non-narcotic ingredients in
24 recognized therapeutic amounts;
25 (6) not more than 300 milligrams of ethylmorphine per
26 100 milliliters or not more than 15 milligrams per dosage
SB1553 - 4 - LRB104 10684 RTM 20763 b
SB1553- 5 -LRB104 10684 RTM 20763 b SB1553 - 5 - LRB104 10684 RTM 20763 b
SB1553 - 5 - LRB104 10684 RTM 20763 b
1 unit, with one or more active, non-narcotic ingredients in
2 recognized therapeutic amounts;
3 (7) not more than 500 milligrams of opium per 100
4 milliliters or per 100 grams, or not more than 25
5 milligrams per dosage unit, with one or more active,
6 non-narcotic ingredients in recognized therapeutic
7 amounts;
8 (8) not more than 50 milligrams of morphine per 100
9 milliliters or per 100 grams with one or more active,
10 non-narcotic ingredients in recognized therapeutic
11 amounts.
12 (f) Anabolic steroids, except the following anabolic
13 steroids that are exempt:
14 (1) Androgyn L.A.;
15 (2) Andro-Estro 90-4;
16 (3) depANDROGYN;
17 (4) DEPO-T.E.;
18 (5) depTESTROGEN;
19 (6) Duomone;
20 (7) DURATESTRIN;
21 (8) DUO-SPAN II;
22 (9) Estratest;
23 (10) Estratest H.S.;
24 (11) PAN ESTRA TEST;
25 (12) Premarin with Methyltestosterone;
26 (13) TEST-ESTRO Cypionates;
SB1553 - 5 - LRB104 10684 RTM 20763 b
SB1553- 6 -LRB104 10684 RTM 20763 b SB1553 - 6 - LRB104 10684 RTM 20763 b
SB1553 - 6 - LRB104 10684 RTM 20763 b
1 (14) Testosterone Cyp 50 Estradiol Cyp 2;
2 (15) Testosterone Cypionate-Estradiol Cypionate
3 injection; and
4 (16) Testosterone Enanthate-Estradiol Valerate
5 injection.
6 (g) Hallucinogenic substances.
7 (1) Dronabinol (synthetic) in sesame oil and
8 encapsulated in a soft gelatin capsule in a U.S. Food and
9 Drug Administration approved product. Some other names for
10 dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-
11 6,6,9-trimethyl-3-pentyl-6H-dibenzo (b,d) pyran-1-ol) or
12 (-)-delta-9-(trans)-tetrahydrocannabinol.
13 (2) (Reserved).
14 (h) The Department may except by rule any compound,
15 mixture, or preparation containing any stimulant or depressant
16 substance listed in subsection (b) from the application of all
17 or any part of this Act if the compound, mixture, or
18 preparation contains one or more active medicinal ingredients
19 not having a stimulant or depressant effect on the central
20 nervous system, and if the admixtures are included therein in
21 combinations, quantity, proportion, or concentration that
22 vitiate the potential for misuse of the substances which have
23 a stimulant or depressant effect on the central nervous
24 system.
25 (Source: P.A. 103-881, eff. 1-1-25.)
SB1553 - 6 - LRB104 10684 RTM 20763 b
SB1553- 7 -LRB104 10684 RTM 20763 b SB1553 - 7 - LRB104 10684 RTM 20763 b
SB1553 - 7 - LRB104 10684 RTM 20763 b
1 (720 ILCS 570/309.1 new)
2 Sec. 309.1. Veterinarian; xylazine. Notwithstanding the
3 scheduling of xylazine as a Schedule III controlled substance,
4 the prohibition on delivery or possession with intent to
5 deliver xylazine does not apply to licensed veterinarians who
6 lawfully prescribe, dispense, administer, acquire, or use any
7 controlled substance, including xylazine, while acting in the
8 course of their professional practice, in good faith, and in
9 accordance with generally accepted medical standards.
10 (720 ILCS 570/401) (from Ch. 56 1/2, par. 1401)
11 Sec. 401. Manufacture or delivery, or possession with
12 intent to manufacture or deliver, a controlled substance, a
13 counterfeit substance, or controlled substance analog. Except
14 as authorized by this Act, it is unlawful for any person
15 knowingly to manufacture or deliver, or possess with intent to
16 manufacture or deliver, a controlled substance other than
17 methamphetamine and other than bath salts as defined in the
18 Bath Salts Prohibition Act sold or offered for sale in a retail
19 mercantile establishment as defined in Section 16-0.1 of the
20 Criminal Code of 2012, a counterfeit substance, or a
21 controlled substance analog. A violation of this Act with
22 respect to each of the controlled substances listed herein
23 constitutes a single and separate violation of this Act. For
24 purposes of this Section, "controlled substance analog" or
25 "analog" means a substance, other than a controlled substance,
SB1553 - 7 - LRB104 10684 RTM 20763 b
SB1553- 8 -LRB104 10684 RTM 20763 b SB1553 - 8 - LRB104 10684 RTM 20763 b
SB1553 - 8 - LRB104 10684 RTM 20763 b
1 which is not approved by the United States Food and Drug
2 Administration or, if approved, is not dispensed or possessed
3 in accordance with State or federal law, and that has a
4 chemical structure substantially similar to that of a
5 controlled substance in Schedule I or II, or that was
6 specifically designed to produce an effect substantially
7 similar to that of a controlled substance in Schedule I or II.
8 Examples of chemical classes in which controlled substance
9 analogs are found include, but are not limited to, the
10 following: phenethylamines, N-substituted piperidines,
11 morphinans, ecgonines, quinazolinones, substituted indoles,
12 and arylcycloalkylamines. For purposes of this Act, a
13 controlled substance analog shall be treated in the same
14 manner as the controlled substance to which it is
15 substantially similar.
16 (a) Any person who violates this Section with respect to
17 the following amounts of controlled or counterfeit substances
18 or controlled substance analogs, notwithstanding any of the
19 provisions of subsections (c), (d), (e), (f), (g) or (h) to the
20 contrary, is guilty of a Class X felony and shall be sentenced
21 to a term of imprisonment as provided in this subsection (a)
22 and fined as provided in subsection (b):
23 (1)(A) not less than 6 years and not more than 30 years
24 with respect to 15 grams or more but less than 100 grams of
25 a substance containing heroin, or an analog thereof;
26 (B) not less than 9 years and not more than 40 years
SB1553 - 8 - LRB104 10684 RTM 20763 b
SB1553- 9 -LRB104 10684 RTM 20763 b SB1553 - 9 - LRB104 10684 RTM 20763 b
SB1553 - 9 - LRB104 10684 RTM 20763 b
1 with respect to 100 grams or more but less than 400 grams
2 of a substance containing heroin, or an analog thereof;
3 (C) not less than 12 years and not more than 50 years
4 with respect to 400 grams or more but less than 900 grams
5 of a substance containing heroin, or an analog thereof;
6 (D) not less than 15 years and not more than 60 years
7 with respect to 900 grams or more of any substance
8 containing heroin, or an analog thereof;
9 (1.5)(A) not less than 6 years and not more than 30
10 years with respect to 15 grams or more but less than 100
11 grams of a substance containing fentanyl or xylazine, or
12 an analog thereof;
13 (B) not less than 9 years and not more than 40 years
14 with respect to 100 grams or more but less than 400 grams
15 of a substance containing fentanyl or xylazine, or an
16 analog thereof;
17 (C) not less than 12 years and not more than 50 years
18 with respect to 400 grams or more but less than 900 grams
19 of a substance containing fentanyl or xylazine, or an
20 analog thereof;
21 (D) not less than 15 years and not more than 60 years
22 with respect to 900 grams or more of a substance
23 containing fentanyl or xylazine, or an analog thereof;
24 (2)(A) not less than 6 years and not more than 30 years
25 with respect to 15 grams or more but less than 100 grams of
26 a substance containing cocaine, or an analog thereof;
SB1553 - 9 - LRB104 10684 RTM 20763 b
SB1553- 10 -LRB104 10684 RTM 20763 b SB1553 - 10 - LRB104 10684 RTM 20763 b
SB1553 - 10 - LRB104 10684 RTM 20763 b
1 (B) not less than 9 years and not more than 40 years
2 with respect to 100 grams or more but less than 400 grams
3 of a substance containing cocaine, or an analog thereof;
4 (C) not less than 12 years and not more than 50 years
5 with respect to 400 grams or more but less than 900 grams
6 of a substance containing cocaine, or an analog thereof;
7 (D) not less than 15 years and not more than 60 years
8 with respect to 900 grams or more of any substance
9 containing cocaine, or an analog thereof;
10 (3)(A) not less than 6 years and not more than 30 years
11 with respect to 15 grams or more but less than 100 grams of
12 a substance containing morphine, or an analog thereof;
13 (B) not less than 9 years and not more than 40 years
14 with respect to 100 grams or more but less than 400 grams
15 of a substance containing morphine, or an analog thereof;
16 (C) not less than 12 years and not more than 50 years
17 with respect to 400 grams or more but less than 900 grams
18 of a substance containing morphine, or an analog thereof;
19 (D) not less than 15 years and not more than 60 years
20 with respect to 900 grams or more of a substance
21 containing morphine, or an analog thereof;
22 (4) 200 grams or more of any substance containing
23 peyote, or an analog thereof;
24 (5) 200 grams or more of any substance containing a
25 derivative of barbituric acid or any of the salts of a
26 derivative of barbituric acid, or an analog thereof;
SB1553 - 10 - LRB104 10684 RTM 20763 b
SB1553- 11 -LRB104 10684 RTM 20763 b SB1553 - 11 - LRB104 10684 RTM 20763 b
SB1553 - 11 - LRB104 10684 RTM 20763 b
1 (6) 200 grams or more of any substance containing
2 amphetamine or any salt of an optical isomer of
3 amphetamine, or an analog thereof;
4 (6.5) (blank);
5 (6.6) (blank);
6 (7)(A) not less than 6 years and not more than 30 years
7 with respect to: (i) 15 grams or more but less than 100
8 grams of a substance containing lysergic acid diethylamide
9 (LSD), or an analog thereof, or (ii) 15 or more objects or
10 15 or more segregated parts of an object or objects but
11 less than 200 objects or 200 segregated parts of an object
12 or objects containing in them or having upon them any
13 amounts of any substance containing lysergic acid
14 diethylamide (LSD), or an analog thereof;
15 (B) not less than 9 years and not more than 40 years
16 with respect to: (i) 100 grams or more but less than 400
17 grams of a substance containing lysergic acid diethylamide
18 (LSD), or an analog thereof, or (ii) 200 or more objects or
19 200 or more segregated parts of an object or objects but
20 less than 600 objects or less than 600 segregated parts of
21 an object or objects containing in them or having upon
22 them any amount of any substance containing lysergic acid
23 diethylamide (LSD), or an analog thereof;
24 (C) not less than 12 years and not more than 50 years
25 with respect to: (i) 400 grams or more but less than 900
26 grams of a substance containing lysergic acid diethylamide
SB1553 - 11 - LRB104 10684 RTM 20763 b
SB1553- 12 -LRB104 10684 RTM 20763 b SB1553 - 12 - LRB104 10684 RTM 20763 b
SB1553 - 12 - LRB104 10684 RTM 20763 b
1 (LSD), or an analog thereof, or (ii) 600 or more objects or
2 600 or more segregated parts of an object or objects but
3 less than 1500 objects or 1500 segregated parts of an
4 object or objects containing in them or having upon them
5 any amount of any substance containing lysergic acid
6 diethylamide (LSD), or an analog thereof;
7 (D) not less than 15 years and not more than 60 years
8 with respect to: (i) 900 grams or more of any substance
9 containing lysergic acid diethylamide (LSD), or an analog
10 thereof, or (ii) 1500 or more objects or 1500 or more
11 segregated parts of an object or objects containing in
12 them or having upon them any amount of a substance
13 containing lysergic acid diethylamide (LSD), or an analog
14 thereof;
15 (7.5)(A) not less than 6 years and not more than 30 years
16 with respect to: (i) 15 grams or more but less than 100
17 grams of a substance listed in paragraph (1), (2), (2.1),
18 (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or
19 (26) of subsection (d) of Section 204, or an analog or
20 derivative thereof, or (ii) 15 or more pills, tablets,
21 caplets, capsules, or objects but less than 200 pills,
22 tablets, caplets, capsules, or objects containing in them
23 or having upon them any amounts of any substance listed in
24 paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20),
25 (20.1), (21), (25), or (26) of subsection (d) of Section
26 204, or an analog or derivative thereof;
SB1553 - 12 - LRB104 10684 RTM 20763 b
SB1553- 13 -LRB104 10684 RTM 20763 b SB1553 - 13 - LRB104 10684 RTM 20763 b
SB1553 - 13 - LRB104 10684 RTM 20763 b
1 (B) not less than 9 years and not more than 40 years
2 with respect to: (i) 100 grams or more but less than 400
3 grams of a substance listed in paragraph (1), (2), (2.1),
4 (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or
5 (26) of subsection (d) of Section 204, or an analog or
6 derivative thereof, or (ii) 200 or more pills, tablets,
7 caplets, capsules, or objects but less than 600 pills,
8 tablets, caplets, capsules, or objects containing in them
9 or having upon them any amount of any substance listed in
10 paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20),
11 (20.1), (21), (25), or (26) of subsection (d) of Section
12 204, or an analog or derivative thereof;
13 (C) not less than 12 years and not more than 50 years
14 with respect to: (i) 400 grams or more but less than 900
15 grams of a substance listed in paragraph (1), (2), (2.1),
16 (2.2), (3), (14.1), (19), (20), (20.1), (21), (25), or
17 (26) of subsection (d) of Section 204, or an analog or
18 derivative thereof, or (ii) 600 or more pills, tablets,
19 caplets, capsules, or objects but less than 1,500 pills,
20 tablets, caplets, capsules, or objects containing in them
21 or having upon them any amount of any substance listed in
22 paragraph (1), (2), (2.1), (2.2), (3), (14.1), (19), (20),
23 (20.1), (21), (25), or (26) of subsection (d) of Section
24 204, or an analog or derivative thereof;
25 (D) not less than 15 years and not more than 60 years
26 with respect to: (i) 900 grams or more of any substance
SB1553 - 13 - LRB104 10684 RTM 20763 b
SB1553- 14 -LRB104 10684 RTM 20763 b SB1553 - 14 - LRB104 10684 RTM 20763 b
SB1553 - 14 - LRB104 10684 RTM 20763 b
1 listed in paragraph (1), (2), (2.1), (2.2), (3), (14.1),
2 (19), (20), (20.1), (21), (25), or (26) of subsection (d)
3 of Section 204, or an analog or derivative thereof, or
4 (ii) 1,500 or more pills, tablets, caplets, capsules, or
5 objects containing in them or having upon them any amount
6 of a substance listed in paragraph (1), (2), (2.1), (2.2),
7 (3), (14.1), (19), (20), (20.1), (21), (25), or (26) of
8 subsection (d) of Section 204, or an analog or derivative
9 thereof;
10 (8) 30 grams or more of any substance containing
11 pentazocine or any of the salts, isomers and salts of
12 isomers of pentazocine, or an analog thereof;
13 (9) 30 grams or more of any substance containing
14 methaqualone or any of the salts, isomers and salts of
15 isomers of methaqualone, or an analog thereof;
16 (10) 30 grams or more of any substance containing
17 phencyclidine or any of the salts, isomers and salts of
18 isomers of phencyclidine (PCP), or an analog thereof;
19 (10.5) 30 grams or more of any substance containing
20 ketamine or any of the salts, isomers and salts of isomers
21 of ketamine, or an analog thereof;
22 (10.6) 100 grams or more of any substance containing
23 hydrocodone, or any of the salts, isomers and salts of
24 isomers of hydrocodone, or an analog thereof;
25 (10.7) (blank);
26 (10.8) 100 grams or more of any substance containing
SB1553 - 14 - LRB104 10684 RTM 20763 b
SB1553- 15 -LRB104 10684 RTM 20763 b SB1553 - 15 - LRB104 10684 RTM 20763 b
SB1553 - 15 - LRB104 10684 RTM 20763 b
1 dihydrocodeine, or any of the salts, isomers and salts of
2 isomers of dihydrocodeine, or an analog thereof;
3 (10.9) 100 grams or more of any substance containing
4 oxycodone, or any of the salts, isomers and salts of
5 isomers of oxycodone, or an analog thereof;
6 (11) 200 grams or more of any substance containing any
7 other controlled substance classified in Schedules I or
8 II, or an analog thereof, which is not otherwise included
9 in this subsection.
10 (b) Any person sentenced with respect to violations of
11 paragraph (1), (2), (3), (7), or (7.5) of subsection (a)
12 involving 100 grams or more of the controlled substance named
13 therein, may in addition to the penalties provided therein, be
14 fined an amount not more than $500,000 or the full street value
15 of the controlled or counterfeit substance or controlled
16 substance analog, whichever is greater. The term "street
17 value" shall have the meaning ascribed in Section 110-5 of the
18 Code of Criminal Procedure of 1963. Any person sentenced with
19 respect to any other provision of subsection (a), may in
20 addition to the penalties provided therein, be fined an amount
21 not to exceed $500,000.
22 (b-1) Excluding violations of this Act when the controlled
23 substance is fentanyl, any person sentenced to a term of
24 imprisonment with respect to violations of Section 401, 401.1,
25 405, 405.1, 405.2, or 407, when the substance containing the
26 controlled substance contains any amount of fentanyl, 3 years
SB1553 - 15 - LRB104 10684 RTM 20763 b
SB1553- 16 -LRB104 10684 RTM 20763 b SB1553 - 16 - LRB104 10684 RTM 20763 b
SB1553 - 16 - LRB104 10684 RTM 20763 b
1 shall be added to the term of imprisonment imposed by the
2 court, and the maximum sentence for the offense shall be
3 increased by 3 years.
4 (c) Any person who violates this Section with regard to
5 the following amounts of controlled or counterfeit substances
6 or controlled substance analogs, notwithstanding any of the
7 provisions of subsections (a), (b), (d), (e), (f), (g) or (h)
8 to the contrary, is guilty of a Class 1 felony. The fine for
9 violation of this subsection (c) shall not be more than
10 $250,000:
11 (1) 1 gram or more but less than 15 grams of any
12 substance containing heroin, or an analog thereof;
13 (1.5) 1 gram or more but less than 15 grams of any
14 substance containing fentanyl, or an analog thereof;
15 (2) 1 gram or more but less than 15 grams of any
16 substance containing cocaine, or an analog thereof;
17 (2.5) 1 gram or more but less than 15 grams of any
18 substance containing xylazine, or an analog thereof;
19 (3) 10 grams or more but less than 15 grams of any
20 substance containing morphine, or an analog thereof;
21 (4) 50 grams or more but less than 200 grams of any
22 substance containing peyote, or an analog thereof;
23 (5) 50 grams or more but less than 200 grams of any
24 substance containing a derivative of barbituric acid or
25 any of the salts of a derivative of barbituric acid, or an
26 analog thereof;
SB1553 - 16 - LRB104 10684 RTM 20763 b
SB1553- 17 -LRB104 10684 RTM 20763 b SB1553 - 17 - LRB104 10684 RTM 20763 b
SB1553 - 17 - LRB104 10684 RTM 20763 b
1 (6) 50 grams or more but less than 200 grams of any
2 substance containing amphetamine or any salt of an optical
3 isomer of amphetamine, or an analog thereof;
4 (6.5) (blank);
5 (7)(i) 5 grams or more but less than 15 grams of any
6 substance containing lysergic acid diethylamide (LSD), or
7 an analog thereof, or (ii) more than 10 objects or more
8 than 10 segregated parts of an object or objects but less
9 than 15 objects or less than 15 segregated parts of an
10 object containing in them or having upon them any amount
11 of any substance containing lysergic acid diethylamide
12 (LSD), or an analog thereof;
13 (7.5)(i) 5 grams or more but less than 15 grams of any
14 substance listed in paragraph (1), (2), (2.1), (2.2), (3),
15 (14.1), (19), (20), (20.1), (21), (25), or (26) of
16 subsection (d) of Section 204, or an analog or derivative
17 thereof, or (ii) more than 10 pills, tablets, caplets,
18 capsules, or objects but less than 15 pills, tablets,
19 caplets, capsules, or objects containing in them or having
20 upon them any amount of any substance listed in paragraph
21 (1), (2), (2.1), (2.2), (3), (14.1), (19), (20), (20.1),
22 (21), (25), or (26) of subsection (d) of Section 204, or an
23 analog or derivative thereof;
24 (8) 10 grams or more but less than 30 grams of any
25 substance containing pentazocine or any of the salts,
26 isomers and salts of isomers of pentazocine, or an analog
SB1553 - 17 - LRB104 10684 RTM 20763 b
SB1553- 18 -LRB104 10684 RTM 20763 b SB1553 - 18 - LRB104 10684 RTM 20763 b
SB1553 - 18 - LRB104 10684 RTM 20763 b
1 thereof;
2 (9) 10 grams or more but less than 30 grams of any
3 substance containing methaqualone or any of the salts,
4 isomers and salts of isomers of methaqualone, or an analog
5 thereof;
6 (10) 10 grams or more but less than 30 grams of any
7 substance containing phencyclidine or any of the salts,
8 isomers and salts of isomers of phencyclidine (PCP), or an
9 analog thereof;
10 (10.5) 10 grams or more but less than 30 grams of any
11 substance containing ketamine or any of the salts, isomers
12 and salts of isomers of ketamine, or an analog thereof;
13 (10.6) 50 grams or more but less than 100 grams of any
14 substance containing hydrocodone, or any of the salts,
15 isomers and salts of isomers of hydrocodone, or an analog
16 thereof;
17 (10.7) (blank);
18 (10.8) 50 grams or more but less than 100 grams of any
19 substance containing dihydrocodeine, or any of the salts,
20 isomers and salts of isomers of dihydrocodeine, or an
21 analog thereof;
22 (10.9) 50 grams or more but less than 100 grams of any
23 substance containing oxycodone, or any of the salts,
24 isomers and salts of isomers of oxycodone, or an analog
25 thereof;
26 (11) 50 grams or more but less than 200 grams of any
SB1553 - 18 - LRB104 10684 RTM 20763 b
SB1553- 19 -LRB104 10684 RTM 20763 b SB1553 - 19 - LRB104 10684 RTM 20763 b
SB1553 - 19 - LRB104 10684 RTM 20763 b
1 substance containing a substance classified in Schedules I
2 or II, or an analog thereof, which is not otherwise
3 included in this subsection.
4 (c-5) (Blank).
5 (d) Any person who violates this Section with regard to
6 any other amount of a controlled or counterfeit substance
7 containing dihydrocodeine or classified in Schedules I or II,
8 or an analog thereof, which is (i) a narcotic drug, (ii)
9 lysergic acid diethylamide (LSD) or an analog thereof, (iii)
10 any substance containing amphetamine or fentanyl or xylazine
11 or any salt or optical isomer of amphetamine or fentanyl or
12 xylazine, or an analog thereof, or (iv) any substance
13 containing N-Benzylpiperazine (BZP) or any salt or optical
14 isomer of N-Benzylpiperazine (BZP), or an analog thereof, is
15 guilty of a Class 2 felony. The fine for violation of this
16 subsection (d) shall not be more than $200,000.
17 (d-5) (Blank).
18 (e) Any person who violates this Section with regard to
19 any other amount of a controlled substance other than
20 methamphetamine or counterfeit substance classified in
21 Schedule I or II, or an analog thereof, which substance is not
22 included under subsection (d) of this Section, is guilty of a
23 Class 3 felony. The fine for violation of this subsection (e)
24 shall not be more than $150,000.
25 (f) Any person who violates this Section with regard to
26 any other amount of a controlled or counterfeit substance
SB1553 - 19 - LRB104 10684 RTM 20763 b
SB1553- 20 -LRB104 10684 RTM 20763 b SB1553 - 20 - LRB104 10684 RTM 20763 b
SB1553 - 20 - LRB104 10684 RTM 20763 b
SB1553 - 20 - LRB104 10684 RTM 20763 b